These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36992247)

  • 41. A randomized controlled trial [corrected] administration of tetanus toxoid (TT) versus tetanus and reduced diphtheria (Td) in pregnant women.
    Salama MM; Hady OA; Ashour W; Mostafa A; El Alkamy S; El Sayed N; El Yazeed RA
    J Clin Immunol; 2009 Jul; 29(4):524-31. PubMed ID: 19363703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of HIV exposure and timing of antiretroviral therapy initiation on immune memory responses to diphtheria, tetanus, whole cell pertussis and hepatitis B vaccines.
    Simani OE; Izu A; Nunes MC; Violari A; Cotton MF; Van Niekerk N; Adrian PV; Madhi SA
    Expert Rev Vaccines; 2019 Jan; 18(1):95-104. PubMed ID: 30417710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.
    Weston WM; Friedland LR; Wu X; Howe B
    Vaccine; 2012 Feb; 30(9):1721-8. PubMed ID: 22212127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low seroprevalence of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination.
    Tanriover MD; Soyler C; Ascioglu S; Cankurtaran M; Unal S
    Eur J Intern Med; 2014 Jul; 25(6):528-32. PubMed ID: 24814432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Effect of Tetanus-Diphtheria-Acellular-Pertussis Immunization During Pregnancy on Infant Antibody Responses: Individual-Participant Data Meta-Analysis.
    Abu-Raya B; Maertens K; Munoz FM; Zimmermann P; Curtis N; Halperin SA; Rots N; Barug D; Holder B; Kampmann B; Leuridan E; Sadarangani M
    Front Immunol; 2021; 12():689394. PubMed ID: 34305922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controls.
    Mischlinger J; Jaeger VK; Ciurea A; Gabay C; Hasler P; Mueller RB; Siegrist CA; Villiger P; Walker UA; Hatz C; Bühler S
    Vaccine; 2022 Aug; 40(33):4897-4904. PubMed ID: 35810064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study.
    Asatryan A; Meyer N; Scherbakov M; Romanenko V; Osipova I; Galustyan A; Shamsheva O; Latysheva T; Myasnikova T; Baudson N; Dodet M; Xavier S; Harrington L; Kuznetsova A; Campora L; Van den Steen P
    Hum Vaccin Immunother; 2021 Mar; 17(3):723-730. PubMed ID: 32845735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Seroprotection rates of vaccine-preventable diseases among newly arrived Eritrean asylum seekers in Switzerland: a cross-sectional study.
    Staehelin C; Chernet A; Sydow V; Piso RJ; Suter-Riniker F; Funez S; Nickel B; Paris DH; Labhardt ND
    J Travel Med; 2019 Sep; 26(6):. PubMed ID: 31094415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diphtheria-tetanus overimmunization in children with no records: can it be prevented?
    Frank JW; Schabas R; Arshinoff R; Brant R
    CMAJ; 1989 Dec; 141(12):1241-6. PubMed ID: 2590890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors Associated with the Uptake of Antenatal Tetanus Toxoids Containing Vaccine by First-Time Mothers in Nigeria: Findings from the 2018 Nigerian Demographic Health Survey.
    Morhason-Bello I; Kareem YO; Illah O; Akinyemi JO; Abdus-Salam R; Lawal O; Bello O; Obajimi G; Adewole IF
    J Pregnancy; 2022; 2022():7607993. PubMed ID: 36157313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
    deBruyn JCC; Soon IS; Fonseca K; Feng S; Purtzki M; Goedhart C; Kuhn S; Vanderkooi OG; Wrobel I
    Inflamm Bowel Dis; 2019 Jun; 25(7):1218-1226. PubMed ID: 30551205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine.
    Weston W; Messier M; Friedland LR; Wu X; Howe B
    Vaccine; 2011 Nov; 29(47):8483-6. PubMed ID: 21945698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seroprevalence of an antibody against diphtheria, tetanus, and pertussis among the elderly in Khon Kaen, Thailand.
    Chinchai T; Posuwan N; Vuthitanachot V; Wanlapakorn N; Poovorawan Y
    J Health Popul Nutr; 2019 Oct; 38(1):28. PubMed ID: 31627764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunity against diphtheria among children and adults in Izmir, Turkey.
    Kurugöl Z; Midyat L; Türkoğlu E; Işler A
    Vaccine; 2011 Jun; 29(26):4341-4. PubMed ID: 21510994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
    Dhillon S
    BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prevalence of diphtheria immunity in healthy population in Poland.
    Walory J; Grzesiowski J; Hryniewicz W
    Epidemiol Infect; 2001 Apr; 126(2):225-30. PubMed ID: 11349973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.
    McCormack PL
    Drugs; 2012 Sep; 72(13):1765-91. PubMed ID: 22931522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune response to a diphtheria and tetanus toxoid administration in a three-dose diphtheria tetanus whole-cell pertussis/enhanced inactivated poliovirus vaccination schedule: a 7-year follow up.
    Swartz TA; Saliou P; Catznelson E; Blondeau C; Gil I; Peled T; Havkin O; Fletcher M
    Eur J Epidemiol; 2003; 18(8):827-33. PubMed ID: 12974560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.